Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Celgene Corp.
DescriptionOral tumor necrosis factor (TNF) alpha inhibitor
Molecular Target Tumor necrosis factor (TNF) alpha
Mechanism of ActionTumor necrosis factor (TNF) alpha inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationLupus
Indication DetailsTreat cutaneous lupus
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today